Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes - 2Tourist trade in Greece and Cyprus suffering from Iran war effects
- 3Top 15 Style Creators Changing the Business
- 4Most loved Occasion Dish: What Makes Your Merry Table?
- 5This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
- 3 moms, 3 countries, 1 very familiar problem: Why child care costs still don't add up for families
- Lilly, Novo lock horns in India's obesity drug race
- 3 Italian City Cars That Outsmarted Regulations and Rivals
- Pfizer says patient dies after receiving hemophilia drug in trial
- How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
- The Most Important Crossroads in Olympic History
- Key takeaways from Sen. Bill Cassidy's interview on 'Face the Nation' with Margaret Brennan
- FDA updates risk classification for voluntary shredded cheese recall
